PARIS, FRANCE and BOSTON, MA / ACCESSWIRE / March 30, 2023 / TISSIUM, a privately-owned medical technology company developing biomorphic programmable polymers for atraumatic tissue reconstruction, ...
CroíValve, a medtech company focused on solutions for tricuspid regurgitation (TR), has announced the initiation of its Early Feasibility Study (EFS) for the DUO Tricuspid Coaptation Valve System, ...
Croívalve Ltd. raised $16 million in a series B financing round that will be used to fund a clinical trial in the U.S. looking at the safety and performance of its Duo system to treat patients with ...
Treatment of Severe Mitral Regurgitation due to Residual Systolic-Anterior Motion of the valve after Surgical Septal Myectomy via Percutaneous Plication utilizing a PASCAL Transcatheter Valve Repair ...
Scientific American is part of Springer Nature, which owns or has commercial relations with thousands of scientific publications (many of them can be found at www ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results